Neratinib ≥95%
Supplier: ADIPOGEN CORP MS
|
Warning
|
Synonyms:
HKI-272, (E)-N-(4-((3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
SYN-1140-M001
SYN-1140-M005
SYN-1140-M010
SYN-1140-M050
102992-312EA
119.08
USD
102992-312
102992-314
102992-316
102992-318
Neratinib ≥95%
Neratinib
Neratinib (HKI-272) is an orally available, irreversible tyrosine kinase inhibitor with IC(50) values of 59nM and 92nM for HER2 and EGFR, respectively. It is in development for the treatment of early- and late-stage HER2-positive breast cancer.
Formula:
C₃₀H₂₉ClN₆O₃ MW: 557 g/mol Storage Temperature: Freezer |
MDL Number:
MFCD09752958 CAS Number: 698387-09-6 |
Specification Test Results
Purity |
|
Appearance/Color | Solid. |
Solubility |
Soluble in DMSO. Slightly soluble ( |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...